Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Viviana Vigo"'
Autor:
Michela Marcenaro, Almalina Bacigalupo, Jean Luis Ravetti, Beatrice Gatteschi, Marco Benasso, Renzo Corvò, Anna Ponzanelli, Viviana Vigo
Publikováno v:
Oral Oncology. 44:767-774
Concomitant chemo-radiotherapy is the standard treatment for advanced nasopharyngeal carcinoma (NPC). Induction chemotherapy may improve the results further by enhancing both loco-regional and distant control. Fifty patients with untreated, stage IV
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::39ed63dace98a6dac68444815bcf5c05
https://doi.org/10.1016/j.oraloncology.2007.09.011
https://doi.org/10.1016/j.oraloncology.2007.09.011
Autor:
Almalina Bacigalupo, Marco Merlano, R. Vitiello, Riccardo Vigna-Taglianti, Ornella Garrone, S. Violante, Viviana Vigo, C. Lo Nigro, Milena Gasco, Gianmauro Numico, Nicola Crosetto, Ida Colantonio, Marco Benasso, Elvio G. Russi, Renzo Corvò
Publikováno v:
Annals of oncology : official journal of the European Society for Medical Oncology. 22(3)
Background Intensification of chemoradiation for advanced head and neck squamous cell carcinoma (HNSCC) is unlikely due to toxicity. Cetuximab combined either with radiotherapy or with chemotherapy showed favourable toxic profile with positive result
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bf4cbfcb70ca018762ff3b3e0b84ca12
https://pubmed.ncbi.nlm.nih.gov/20810547
https://pubmed.ncbi.nlm.nih.gov/20810547
Autor:
Almalina Bacigalupo, Viviana Vigo, Marco Benasso, Anna Ponzanelli, Michela Marcenaro, Renzo Corvò, G. Margarino
Publikováno v:
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology. 89(1)
Background The addition of gemcitabine may be a reasonable way to enhance the activity of the alternating cisplatin/5-fluorouracil and radiation regimen considered the referring approach for patients with advanced squamous cell carcinoma (SCC) of the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fa3a623d80c18d4353cea947ef0b0632
https://pubmed.ncbi.nlm.nih.gov/18423671
https://pubmed.ncbi.nlm.nih.gov/18423671
Autor:
A. Bacigalupo, L. Berretta, Marco Merlano, Stefania Vecchio, M. Aieta, N. D'Abbiero, S. Bui, L. Canobbio, Viviana Vigo, Elvio G. Russi, Marco Benasso, Nerina Denaro, A. Grimaldi, Cristiana Bergamini, M. Rampino, Ester Orlandi, O. Ostellino, M. D'amico, F. Blengio, Gianmauro Numico
Publikováno v:
European Journal of Cancer. 51:S560
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a3c0b3b0b7afd99967fb89e3831aa666
https://doi.org/10.1016/s0959-8049(16)31564-7
https://doi.org/10.1016/s0959-8049(16)31564-7
Autor:
Riccardo Rosso, Giovanna Cavallo, Marco Benasso, Gianmauro Numico, Francesco Grossi, Isabella Ricci, Paola Taveggia, Anna Ponzanelli, Viviana Vigo, Marco Merlano, Barbara Capaccetti, Dino Amadori, Luca Boni
The aim of this multicenter trial was to test the feasibility and the activity of a three-drug combination where paclitaxel is added to cisplatin and 5-fluorouracil. Patients with metastatic or relapsed SCC-HN unsuitable for further loco-regional rad
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fd10fef018aed2285ea100f673ba495d
http://hdl.handle.net/11383/2119028
http://hdl.handle.net/11383/2119028
